Allergy Thera (AGY)

Allergy Therapeutics PLC Vesting of Options under Long-Term Incentive Plan

Allergy Therapeutics PLC 30 June 2026     Allergy Therapeutics plc ("Allergy Therapeutics" or the "Company")   Vesting of Options under...

Allergy Therapeutics PLC Long Term Incentive Awards

Allergy Therapeutics PLC 15 June 2026   Allergy Therapeutics plc ("Allergy Therapeutics" or the "Company")   Long Term Incentive Awards   15...

Allergy Therapeutics PLC Allergy Therapeutics to present at EAACI 2026

Allergy Therapeutics PLC 12 June 2026     Allergy Therapeutics plc ("Allergy Therapeutics" or the "Company" or "Group")   Allergy Therapeutics...

Edison - Allergy Therapeutics:H126 results reflect solid progress

Cavendish - Morning Note – 31 March 2026

Cavendish - Allergy Therapeutics - 1H26 interims: Grassmuno launch underway

Allergy Therapeutics (AGY) has announced its 6-month interim results to end-December 2025, in line with the January trading update. 1H26 group...

Allergy Therapeutics PLC Interim Results for six months ended 31 Dec 2025

Allergy Therapeutics PLC 31 March 2026     Allergy Therapeutics plc ("Allergy Therapeutics" or the "Company" or the "Group")   Interim Results...

Allergy Therapeutics PLC PDMR Dealings & Shareholding Update

Allergy Therapeutics PLC 12 March 2026     Allergy Therapeutics plc ("Allergy Therapeutics" or the "Company")   PDMR Dealings &...

Allergy Therapeutics PLC Positive Biomarker Results from PROTECT Trial

Allergy Therapeutics PLC 04 March 2026       Allergy Therapeutics plc ("Allergy Therapeutics", "ATL" or the "Group")   Positive biomarker...

Allergy Therapeutics PLC Allergy Therapeutics presents progress at AAAAI

Allergy Therapeutics PLC 26 February 2026     Allergy Therapeutics plc ("Allergy Therapeutics" or the "Company" or "Group")   Allergy...

Allergy Therapeutics PLC Update on funding and total voting rights

Allergy Therapeutics PLC 23 February 2026   Allergy Therapeutics plc ("Allergy Therapeutics" or the "Company")   Update on funding   and   Total...

Allergy Therapeutics PLC Chief Strategy Officer and Board appointments

Allergy Therapeutics PLC 30 January 2026     Allergy Therapeutics plc ("Allergy Therapeutics" or the "Company" or "Group")   Allergy...

Allergy Therapeutics PLC Result of Annual General Meeting

Allergy Therapeutics PLC 29 January 2026     Allergy Therapeutics plc ("Allergy Therapeutics" or the "Group")   Result of Annual General Meeting...

Allergy Therapeutics PLC Grant of Options under Long Term Incentive Scheme

Allergy Therapeutics PLC 28 January 2026   Allergy Therapeutics plc ("Allergy Therapeutics" or the "Company" or the "Group")   Grant of Options...

Allergy Therapeutics Delivers 7% Revenue Growth in First Half and Launches Grassmuno

Allergy Therapeutics plc (LSE:AGY) reported first-half revenue of £36.3 million for the six months ended 31 December, representing year-on-year...